Under the Bangladesh Millennium Development Goal 4 program, which aims to cut mortality in children aged under five, the Ministry of Health and Family Welfare is introducing a new combination vaccine that will protect them from five killer diseases in one injection including, for the first time, the deadly bacterium Haemophilus influenzae. The vaccine will be provided under the routine immunization program to nearly four million children born in Bangladesh every year. The GAVI Alliance will spend more than $95.0 million for procuring some 27 million doses for 2009-2010, and the Bangladesh government will invest $5.6 million over this time.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze